A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR ...

In the study, the research team used cell-based, tissue-based, and preclinical models of proliferative vitreoretinopathy ... related macular degeneration and diabetic retinopathy.